Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ raptor resources limited

Ann: ResAppDx-EU in Use at COVID-19 Respiratory Clinic, page-187

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 187 Last

Share
Profile

Follow
TheSanDiegoKid

724 Posts.

356

31/08/20

16:31

Post #: 46960080
Share

Originally posted by Dhm: ↑

I rang the Morayfield Clinic this morning and Dr Evan Jones the Director of Health Hub rang me back just then. He was effusive in his praise of Dx. He told me it was invaluable in its ability to triage and diagnose patients who present to the clinic. In fact some diagnoses of pneumonia were made via the app that weren’t otherwise picked up by the clinicians.
The only slight downside was the constant cleaning of the phone temporarily caused a blockage of the microphone. Now they have a cover over the phone and that problem hasn’t re emerged.
I asked Dr Jones whether the clinic wants to continue with the licensing agreement and he gave me an emphatic yes. He has already contacted ResApp with that request. I did not ask anything about licensing fees.

To me this is a further de risking of our company because it demonstrates the much needed early adoption of Dx by both face to face diagnostic situations and Telehealth providers.

Expand

Legend! Solid work, mate!

RAP Price at posting: 12.0¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

Emerald & Azure score Digger & Dealer awards

MXR

Maximus picks up 25.93 g/t of gold through infill drilling at WA's Hilditch

Earnings Wrap: why is the utilities sector tanking & other big name earnings on Thursday

Bitcoin: Current State of Play & Where to Next | Swyftx

OSL

Oncosil device successfully treats pancreatic cancer in Türkiye

There are more pages in this discussion • 9 more messages in this thread...

First 187 Last

Add RAP (ASX) to my watchlist

SPONSORED BY